Skip to main content

Table 1 Characteristics of the study population

From: Prevalence and clinical associations of wheezes and crackles in the general population: the Tromsø study

 

Male

(n = 1874)

n (%)

Female

(n = 2159)

n (%)

Missing

(n = 4033)

n (%)

Age

63.7 (±10.5)

63.4 (±10.7)

 

  < 65 years

908 (48.5%)

1071 (49.6%)

 

  ≥ 65 years

966 (51.5%)

1088 (50.4%)

 

Body-mass index

12 (0.3%)

  < 30

1425 (76.0%)

1683 (78.0%)

 

  ≥ 30

445 (23.7%)

468 (21.7%)

 

Smoking status

59 (1.5%)

 Never smoker

686 (36.6%)

916 (42.4%)***

 

 Current smoker

208 (11.1%)

269 (12.5%)

 

 Previous smoker

954 (50.9%)

941 (43.6%)***

 

Self-reported disease

 

 Hypertension

473 (25.2%)

557 (25.8%)

119 (3.0%)

 Myocardial Infarction

141 (7.5%)

57 (2.6%)***

171 (4.2%)

 Heart failure

33 (1.8%)

16 (0.7%)**

175 (4.3%)

 Atrial Fibrillation

92 (4.9%)

80 (3.7%)

178 (4.4%)

 COPD

74 (3.9%)

87 (4.0%)

157 (3.9%)

 Asthma

128 (6.8%)

196 (9.1%)**

254 (6.3%)

 Rheumatoid arthritis

83 (4.4%)

117 (5.4%)

227 (5.6%)

 Airways infection last week §

278 (14.8%)

303 (14.0%)

165 (4.1%)

Dyspnea

mMRC

165 (4.1%)

 mMRC 0

1323 (70.6%)

1368 (63.4%)***

 

 mMRC 1

412 (22.0%)

575 (26.6%)***

 

 mMRC 2–4

70 (3.7%)

120 (5.6%)**

 

 Breathing worse than usual §

210 (11.2%)

242 (11.2%)

156 (3.9%)

Oxygen saturation, SpO2

161 (4.0%)

  ≤ 95%

110 (5.9%)

72 (3.3%)***

 

Spirometry

 FEV1 < LLN †

150 (8.0%)

136 (6.3%)

234 (5.8%)

  1. Abbreviations: mMRC = Modified Medical Research Council questionnaire, FEV1 = Forced Expiratory Volume in one second, LLN = Lower Limit of Normal
  2. §On examination day
  3. ***p value <.001, **p value <.01, *p value <.05 as compared to male by X2 test